Page last updated: 2024-09-05
tesaglitazar and aprepitant
tesaglitazar has been researched along with aprepitant in 1 studies
Compound Research Comparison
Studies (tesaglitazar) | Trials (tesaglitazar) | Recent Studies (post-2010) (tesaglitazar) | Studies (aprepitant) | Trials (aprepitant) | Recent Studies (post-2010) (aprepitant) |
---|---|---|---|---|---|
74 | 13 | 25 | 769 | 229 | 521 |
Protein Interaction Comparison
Protein | Taxonomy | tesaglitazar (IC50) | aprepitant (IC50) |
---|---|---|---|
Cytochrome P450 3A4 | Homo sapiens (human) | 0.046 | |
Substance-P receptor | Homo sapiens (human) | 0.0002 | |
Substance-P receptor | Meriones unguiculatus (Mongolian gerbil) | 0.0001 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Other Studies
1 other study(ies) available for tesaglitazar and aprepitant
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |